vs
Side-by-side financial comparison of AbbVie (ABBV) and Caterpillar Inc. (CAT). Click either name above to swap in a different company.
Caterpillar Inc. is the larger business by last-quarter revenue ($85.0B vs $15.0B, roughly 5.7× AbbVie). On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs -17.7%). Over the past eight quarters, Caterpillar Inc.'s revenue compounded faster (125.7% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Caterpillar Inc. is an American construction, mining, and other engineering equipment manufacturer. The company is the world's largest manufacturer of construction equipment. In 2018, Caterpillar was ranked number 73 on the Fortune 500 list and number 265 on the Global Fortune 500 list. Caterpillar stock is a component of the Dow Jones Industrial Average.
ABBV vs CAT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $85.0B |
| Net Profit | $697.0M | — |
| Gross Margin | — | 89.5% |
| Operating Margin | 26.6% | 3.0% |
| Net Margin | 4.6% | — |
| Revenue YoY | 9.9% | -17.7% |
| Net Profit YoY | -46.0% | — |
| EPS (diluted) | $0.39 | $4.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | $85.0B | ||
| Q4 25 | $16.6B | $19.1B | ||
| Q3 25 | $15.8B | $17.6B | ||
| Q2 25 | $15.4B | $16.6B | ||
| Q1 25 | $13.3B | $14.2B | ||
| Q4 24 | $15.1B | $16.2B | ||
| Q3 24 | $14.5B | $16.1B | ||
| Q2 24 | $14.5B | $16.7B |
| Q1 26 | $697.0M | — | ||
| Q4 25 | $1.8B | $2.4B | ||
| Q3 25 | $186.0M | $2.3B | ||
| Q2 25 | $938.0M | $2.2B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $-22.0M | $2.8B | ||
| Q3 24 | $1.6B | $2.5B | ||
| Q2 24 | $1.4B | $2.7B |
| Q1 26 | — | 89.5% | ||
| Q4 25 | 72.6% | 30.5% | ||
| Q3 25 | 66.4% | 33.8% | ||
| Q2 25 | 71.8% | 34.8% | ||
| Q1 25 | 70.0% | 37.1% | ||
| Q4 24 | 70.9% | 36.3% | ||
| Q3 24 | 70.9% | 37.5% | ||
| Q2 24 | 70.9% | 39.2% |
| Q1 26 | 26.6% | 3.0% | ||
| Q4 25 | 27.3% | 13.9% | ||
| Q3 25 | 12.1% | 17.3% | ||
| Q2 25 | 31.7% | 17.3% | ||
| Q1 25 | 28.0% | 18.1% | ||
| Q4 24 | -9.9% | 18.0% | ||
| Q3 24 | 26.5% | 19.5% | ||
| Q2 24 | 27.6% | 20.9% |
| Q1 26 | 4.6% | — | ||
| Q4 25 | 10.9% | 12.5% | ||
| Q3 25 | 1.2% | 13.0% | ||
| Q2 25 | 6.1% | 13.2% | ||
| Q1 25 | 9.6% | 14.1% | ||
| Q4 24 | -0.1% | 17.2% | ||
| Q3 24 | 10.8% | 15.3% | ||
| Q2 24 | 9.5% | 16.1% |
| Q1 26 | $0.39 | $4.20 | ||
| Q4 25 | $1.02 | $5.11 | ||
| Q3 25 | $0.10 | $4.88 | ||
| Q2 25 | $0.52 | $4.62 | ||
| Q1 25 | $0.72 | $4.20 | ||
| Q4 24 | $-0.03 | $5.76 | ||
| Q3 24 | $0.88 | $5.06 | ||
| Q2 24 | $0.77 | $5.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.0M |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | — | $21.3M |
| Total Assets | — | $98.6M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $10.0M | ||
| Q4 25 | $5.3B | $10.0B | ||
| Q3 25 | $5.7B | $7.5B | ||
| Q2 25 | $6.5B | $5.4B | ||
| Q1 25 | $5.2B | $3.6B | ||
| Q4 24 | $5.6B | $6.9B | ||
| Q3 24 | $7.3B | $5.6B | ||
| Q2 24 | $13.2B | $4.3B |
| Q1 26 | — | $0 | ||
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | — |
| Q1 26 | — | $21.3M | ||
| Q4 25 | $-3.3B | $21.3B | ||
| Q3 25 | $-2.6B | $20.7B | ||
| Q2 25 | $-183.0M | $18.7B | ||
| Q1 25 | $1.4B | $18.1B | ||
| Q4 24 | $3.3B | $19.5B | ||
| Q3 24 | $6.0B | $19.4B | ||
| Q2 24 | $6.8B | $17.1B |
| Q1 26 | — | $98.6M | ||
| Q4 25 | $134.0B | $98.6B | ||
| Q3 25 | $133.9B | $93.7B | ||
| Q2 25 | $137.2B | $90.3B | ||
| Q1 25 | $136.2B | $85.0B | ||
| Q4 24 | $135.2B | $87.8B | ||
| Q3 24 | $143.4B | $86.3B | ||
| Q2 24 | $141.9B | $83.3B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
